Adjuncts for ovarian stimulation: when do we adopt "orphan indications" for approved drugs?

Fertility and Sterility

Volumn 92, Issue 1, 2009, Pages 13-18

  Meldrum, David R ^a   Chang, R Jeffrey ^b   de Ziegler, Dominique ^c   Schoolcraft, William B ^d   Scott Jr , Richard T ^e   Pellicer, Antonio ^f  

^a Reproductive Partners Medical Group   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d National Foundation for Fertility Research   (United States)

^e REPRODUCTIVE MEDICINE ASSOCIATES OF NEW JERSEY   (United States)

^f UNIVERSITY OF VALENCIA   (Spain)

Author keywords

androgens; aspirin; cabergoline; dexamethazone; hCG; metformin; Ovarian stimulation

Indexed keywords

ACETYLSALICYLIC ACID; CABERGOLINE; CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; DEXAMETHASONE; ESTROGEN; FLUTAMIDE; FOLLITROPIN; GLUCOCORTICOID; GONADORELIN AGONIST; GROWTH HORMONE; HUMAN MENOPAUSAL GONADOTROPIN; INSULIN; LETROZOLE; LEUPRORELIN; METFORMIN; ORAL CONTRACEPTIVE AGENT; ORPHAN DRUG; PRASTERONE; SOMATOMEDIN C; TESTOSTERONE; TRANSCRIPTION FACTOR HOXA10;

APOPTOSIS; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CRYOPRESERVATION; CYST; DIZZINESS; DRUG INDICATION; DRUG MECHANISM; DRUG SAFETY; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FETUS DISEASE; HEADACHE; HUMAN; HYPERPROLACTINEMIA; HYPOGONADOTROPIC HYPOGONADISM; LACTIC ACIDOSIS; LOW DRUG DOSE; META ANALYSIS; NAUSEA; OVARY FUNCTION; OVARY HYPERSTIMULATION; OVULATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; SYSTEMATIC REVIEW; VALVULAR HEART DISEASE;

ANDROGENS; ASPIRIN; CONTRACEPTIVES, ORAL; DOPAMINE AGONISTS; ESTROGENS; FEMALE; FERTILIZATION IN VITRO; HUMAN GROWTH HORMONE; HUMANS; LEUPROLIDE; METFORMIN; ORPHAN DRUG PRODUCTION; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME;

EID: 67649132605     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.03.081     Document Type: Article

References (45)

1. Meldrum D.R., Wisot A., Hamilton F., Gutlay A.L., Kempton W.F., and Huynh D. Routine pituitary suppression with leuprolide before ovarian stimulation for oocyte retrieval. Fertil Steril 51 (1989) 455-459
2. Hughes E.G., Fedorkow D.M., Daya S., Sagle M.A., Van de Koppel P., and Collins J.A. The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials. Fertil Steril 58 (1992) 888-896
3. Biljan M.M., Mahutte N.G., Dean N., Hemmings R., Bissonnette F., and Tan S.L. Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates. Fertil Steril 70 (1998) 1063-1069
4. de Zeigler D., Jaaskelainen A.S., Brioschi P.A., Fanchin R., and Bulletti C. Synchronization of endogenous and exogenous FSH stimuli in controlled ovarian hyperstimulation (COH). Hum Reprod 13 (1998) 561-564
5. Fanchin R., Salomon L., Castelo-Branco A., Olivennes F., Frydman N., and Frydman R. Luteal estradiol pre-treatment coordinates follicular growth during controlled ovarian hyperstimulation with GnRH antagonists. Hum Reprod 18 (2003) 2698-2703
6. Frattarelli J.L., Hill M.J., McWilliams G.D., Miller K.A., Bergh P.A., and Scott R.T. A luteal estradiol protocol for expected poor-responders improves embryo number and quality. Fertil Steril 89 (2008) 1118-1122
7. Costello M.F., Chapman M., and Conway U. A systematic review and meta-analysis of randomized controlled trials on metformin co-administration during gonadotrophin ovulation induction or IVF in women with polycystic ovary syndrome. Hum Reprod 21 (2006) 1387-1399
8. Chang R.J., Nakamura R.M., Judd H.L., and Kaplan S.A. Insulin resistance in nonobese patients with polycystic ovarian disease. J Clin Endocrinol Metab 57 (1983) 356-359
9. Agrawal R., Jacobs H., Payne N., and Conway G. Concentration of vascular endothelial growth factor released by cultured luteinized granulosa cells is higher in women with polycystic ovaries than in women with normal ovaries. Fertil Steril 78 (2002) 1164-1169
10. Meldrum D.R. Vascular endothelial growth factor, polycystic ovary syndrome, and ovarian hyperstimulation syndrome. Fertil Steril 78 (2002) 1170-1171
11. Tang T., Glanville J., Orsi N., Barth J.H., and Balen A.H. The use of metformin for women with PCOS undergoing IVF treatment. Hum Reprod 21 (2006) 1416-1425
12. Stadtmauer L.A., Toma S.K., Reihl R.M., and Talbert L.M. Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin-like growth factors. Fertil Steril 75 (2001) 505-509
13. Creanga A.A., Bradley H.M., McCormick C., and Witkop C.T. Use of metformin in polycystic ovary syndrome: a meta-analysis. Obstet Gyneco 111 (2008) 959-968
14. De Leo V., la Marca A., Ditto A., Morgante G., and Cianci A. Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome. Fertil Steril 72 (1999) 282-285
15. Jakubowicz D.J., Seppala M., Jakubowicz S., Rodriguez-Armas O., Rivas-Santiago A., Koistinen H., et al. Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome. J Clin Endocrinol Metab 86 (2001) 1126-1133
16. Ajossa S., Guerriero S., Paoletti A.M., Orru M., and Melis J.B. The antiandrogenic effect of flutamide improves uterine perfusion in women with polycystic ovary syndrome. Fertil Steril 77 (2002) 1136-1140
17. Cermik D., Selam B., and Taylor H.S. Regulation of HOXA-10 expression by testosterone in vitro and in the endometrium of patients with polycystic ovary syndrome. J Clin Endocrinol Metab 88 (2003) 238-243
18. Harper K., Proctor M., and Hughes E. Growth hormone for in vitro fertilization. Cochrane Database Syst Rev 3 (2003) 1-33
19. Tesarik J., Hazout A., and Mendoza C. Improvement of delivery and live birth rates after ICSI in women aged >40 years by ovarian co-stimulation with growth hormone. Hum Reprod 20 (2005) 2536-2541
20. Schoolcraft W., Schlenker T., Gee M., Stevens J., and Wagley L. Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a microdose follicle-stimulating hormone flare, growth hormone protocol. Fertil Steril 67 (1997) 93-97
21. Bencomo E., Perez R., Arteaga M.F., Acosta E., Pena O., Lopez L., et al. Apoptosis of cultured granulosa-lutein cells is reduced by insulin-like growth factor I and may correlate with embryo fragmentation and pregnancy rate. Fertil Steril 85 (2006) 474-480
22. Daly D.C., Walters C.A., Soto-Albors C.E., Tohan N., and Riddick D.H. A randomized study of dexamethasone in ovulation induction with clomiphene citrate. Fertil Steril 41 (1984) 844-848
23. Lobo R.A., Wellington P., March C.M., Granger L., and Kletsky O.A. Clomiphene and dexamethasone in women unresponsive to clomiphene alone. Obstet Gynecol 60 (1982) 497-501
24. Trott E.A., Plouffe L., Hansen K., Hines R., Brann D.W., and Mahesh V.B. Ovulation induction in clomiphene-resistant anovulatory women with normal dehydroepiandrosterone sulfate levels: beneficial effects of the addition of dexamethasone during the follicular phase. Fertil Steril 66 (1996) 484-486
25. Parsanezhad M.E., Alborzi S., Motazedian S., and Omrani G. Use of dexamethasone and clomiphene citrate in the treatment of clomiphene citrate-resistant patients with polycystic ovary syndrome and normal dehydroepiandrosterone sulfate levels: a prospective, double-blind, placebo-controlled trial. Fertil Steril 78 (2002) 1001-1004
26. Elnashar A., Abdelmageed E., Fayed M., and Sharaf M. Clomiphene citrate and dexamethasone in treatment of clomiphene citrate-resistant polycystic ovary syndrome: a prospective placebo-controlled study. Hum Reprod 21 (2006) 1805-1808
27. Keay S.D., Lenton E.A., Cooke I.D., Hull M.G.R., and Jenkins J.M. Low-dose dexamethasone augments the ovarian response to exogenous gonadotropins leading to a reduction in cycle cancellation rate in a standard IVF programme. Hum Reprod 16 (2001) 1861-1865
28. Thurston L.M., Norgate D.P., Jonas K.C., Gregory L., Wood P.J., and Cooke B.A. Ovarian modulators of type 1 11beta-hydroxysteroid dehydrogenase (11betaHSD) activity and intra-follicular cortisol:cortisone ratios correlate with the clinical outcome of IVF. Hum Reprod 18 (2003) 1603-1612
29. Lewicka S., von Hagens C., Hettinger U., Grunwald K., Vecsei P., Runnebaum B., et al. Cortisol and cortisone in human follicular fluid and serum and the outcome of IVF treatment. Hum Reprod 18 (2003) 1613-1617
30. Thompson K.A., La Polt P.S., Rivier J., Henderson G., Dahl K., and Meldrum D.R. Gonadotropin requirements of the developing follicle. Fertil Steril 63 (1995) 273-276
31. Filicori M., Cognigni G.E., Taraborrelli S., Spettoli D., Ciampaglia W., and de Fatis C.D. Low-dose human chorionic gonadotropin therapy can improve sensitivity to exogenous follicle-stimulating hormone in patients with secondary amenorrhea. Fertil Steril 72 (1999) 1118-1120
32. Rubinstein M., Marazzi A., and Polak de Fried E. Low-dose aspirin treatment improves ovarian responsiveness, uterine and ovarian blood flow velocity, implantation, and pregnancy rates in patients undergoing in vitro fertilization: a prospective, randomized, double-blind placebo-controlled assay. Fertil Steril 71 (1999) 825-829
33. Khairy M., Banerjee K., El-Toukhy T., Coomarasamy A., and Khalaf Y. Aspirin in women undergoing in vitro fertilization treatment: a systematic review and meta-analysis. Fertil Steril 88 (2007) 822-831
34. Waldenstrom U., Hellberg D., and Nilsson S. Low-dose aspirin in a short regimen as standard treatment in in vitro fertilization: a randomized, prospective study. Fertil Steril 81 (2004) 1560-1564
35. Ruopp M.D., Collins T.C., Whitcomb B.W., and Schisterman E.F. Evidence of absence or absence of evidence? A reanalysis of the effects of low dose aspirin in in vitro fertilization. Fertil Steril 90 (2008) 71-76
36. Alverez C., Marti-Bonmati L., Novella-Maestre E., Sanz R., Gomez R., Fernandez-Sanchez M., et al. Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction. J Clin Endocrinol Metab 92 (2007) 2931-2937
37. Alverez C., Alonso-Muriel I., Garcia G., Crespo J., Bellver J., Simon C., et al. Implantation is apparently unaffected by the dopamine agonist cabergoline when administered to prevent ovarian hyperstimulation syndrome in women undergoing assisted reproduction treatment: a pilot study. Hum Reprod 22 (2007) 3210-3214
38. Soares S.R., Gomez R., Simon C., Garcia-Velasco J.A., and Pellicer A. Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome. Hum Reprod Update 14 (2008) 321-333
39. Schade R., and Andersoh F. Suissa, S, Haverkamp W, Garbe E. Dopamine agonist and the risk of cardiac-valve regurgitation. N Engl J Med 356 (2007) 29-38
40. Balasch J., Frabregues F., Penarrubia J., Carmona F., Casamitjana R., Creus M., et al. Pretreatment with transdermal testosterone may improve ovarian response to gonadotrophins in poor-responder IVF patients with normal basal concentrations of FSH. Hum Reprod 21 (2006) 1884-1893
41. Garcia-Velasco J.A., Moreno L., Pacheco A., Guillen A., Duque L., Requena A., et al. The aromatase inhibitor letrozole increases the concentration of ovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study. Fertil Steril 84 (2005) 82-87
42. Barad D., Brill H., and Gleicher N. Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function. J A R G 24 (2007) 629-634
43. Weil S.J., Vendola K., Zhou J., Adesanya O.O., Wang J., Okafor J., et al. Androgen receptor gene expression in the primate ovary: cellular localization, regulation, and functional correlations. J Clin Endocrinol Metab 83 (1998) 2479-2485
44. Massin N., Cedrin-Durnerin I., Coussieu C., Galey-Fontaine J., Wolf J.P., and Hugues J.N. Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproduction technique-a prospective, randomized, double-blind study. Hum Reprod 21 (2006) 1204-1211
45. Tulandi T., Martin J., Al-Fadhli R., Kabli N., Forman R., and Hitkari J. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertil Steril 85 (2006) 1761-1765